Document is current
Any future updates will be listed below
-
Authors
Kanazawa, Jun
Kitazawa, Haruna
Masuko, Hironori https://orcid.org/0000-0002-5917-7973
Yatagai, Yohei
Sakamoto, Tohru
Kaneko, Yoshiko
Iijima, Hiroaki
Naito, Takashi
Saito, Takefumi
Noguchi, Emiko
Konno, Satoshi
Nishimura, Masaharu
Hirota, Tomomitsu
Tamari, Mayumi
Hizawa, Nobuyuki
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP15H04827)
- License Information
-
More Information
Article History
Received: 2 December 2018
Accepted: 18 March 2019
First Online: 2 April 2019
Ethics approval and consent to participate
: This study was approved by the Human Genome Analysis and Epidemiology Research Ethics Committee of the University of Tsukuba as well as by the Human Genome/Gene Analysis Research Ethics Review Committees of the Tsukuba Medical Center and of RIKEN. Written informed consent was obtained from each participant before the study, which was performed in accordance with the principles of the Declaration of Helsinki.
: All participants have given their written informed consents for publication of this study.
: NH has received lecture fees from AstraZeneca, Astellas Pharma Inc., and Boehringer Ingelheim. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
